Skip to content

Cutaneous Side Effects of Novel Anti-Melanoma Drugs

A/Prof Pablo Fernandez-Peñas was invited to attend the 7th Annual Meeting of the Asian Society for Pigment Cell Researchin Shanghai (China). He reviewed our papers on the Cutaneous Side Effects of BRAF inhibitors, MEK inhibitors, anti-CTLA4 and anti-PD1 therapies (Publications) and new results not yet published. Although melanoma is not as a big issue in most …

2015 Cancer Life-span Symposium – FROM THE VERY BEGINNING TO THE END OF LIFE: CANCER OVER THE LIFESPAN

Ali Azimi, PhD student from our department has been on the organising committee for 2015 Cancer Life-span Symposium. Congratulations Ali for the great work! ***************** The 2015 Cancer Life-span Symposium was held on 9th of September at the Westmead Millennium Institute and more than 90 cancer researchers had attended the symposium. The symposium which was …

Sun protection is not just for summer

A/Prof Pablo Fernandez-Peñas was interviewed regarding sun protection and winter months. This interview appeared in the Manly Daily newspaper. The message is clear: “We can’t feel UV light, and the heat sensation is not related to the amount of UV light”. If you want to read the rest of the interview, you should be able …

Westmead Hospital Week – Dermatology

Westmead Hospital week research symposium is on from 19th of August until 21st of August 2015. Dermatology has 5 posters (Poster numbers 18-22) on display covering recent topics in melanoma therapy including BRAF inhibitors and targeted immunotherapies. We are also presenting the exciting first set of data on proteomics analysis of squamous cell carcinoma, one …

Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors

We have reviewed, in our population of patients with metastatic melanoma on targeted therapies, the cutaneous side effects of BRAF single agent (Dabrafenib or Vemurafenib) and the combination therapy (Dabrafenib + Trametinib). There are minimal differences between Dabrafenib and Vemurafenib (being photosensitivity the most important), but there are very significant differences between Dabrafenib and the …

Psoriasis: Beyond Skin Control

A/Prof. Pablo Fernandez-Peñas has just arrived from Hsinchu (Taiwan) and Hong Kong. He was invited to talk about psoriasis, and, in particular, why we have to treat more than the skin, in two IMID (Immune Mediated Inflammatory Diseases) meetings. Gastroenterologists, Rheumatologists and Dermatologists from East Asia attended these meetings sponsored by Abvvie. Pablo reviewed the …

Proteomic Data Analyses Using IPA

Often, it is very challenging to analyze and interpret the large data generated by techniques such as microarray and mass spectrometry. To overcome this issue, there have been few bioinformatics tools such as Ingenuity Pathway Analysis (IPA) developed that use the information already available in the literature to map the set of experimental data to …

Awards to Westmead Dermatology research

First year Dermatology registrar Dr Burcu Kim has recently received 2 awards for her research, conducted at the Skin Hospital (Skin & Cancer Foundation Australia) with A/Prof Pablo Fernández-Peñas, titled ‘Scar outcomes in Dermatologic Surgery’. The Eileen Collins Memorial Prize, sponsored by the NSW faculty, and the Best Paper in the Registrars Forum at the …

What’s new in Melanoma – GP Information Session

Department of Dermatology in conjunction with the Westmead Melanoma Unit and Sydney West Translational Cancer Research Centre is hosting a free information evening for GPs on Thursday 30th of July 2015 (6.30 to 8.30pm) held at Westmead Hospital, Lecture Theatre 3, Education Block. This information session covers the latest developments in diagnosis and treatment available …